|
|
Recommended Results |
|
|
|
公司介紹 |
|
Weith Pharmaceutical (Shanghai) Technology Co., Ltd. is a leading Hi-Tech pharmaceutical company. Weith Pharmaceutical integrates R&D, production, sales, and trading of Active Pharmaceutical Ingredients (APIs) and Key Intermediates, covering the industrial chain. Weith Pharmaceutical is dedicated to providing first-class quality products for human health. Based in Wuhan, Weith Pharmaceutical is currently setting up a business center in Shanghai.
There are approximately 200 employees working in the Weith Pharmaceutical family, with 24 very experienced senior technical managers coming from the chemistry synthesis and biopharmaceutical fields. A strong R&D ability is the company’s core competency for sustainable growth. Supported by advanced technology, Weith Pharmaceutical has been taking the lead position in the R&D and industrialization area in China. Wholly or partly invested by Weith Pharmaceutical, there are four production bases for APIs and Intermediates, two are GMP-compliant and two are FDA-approved facilities All production and procedures are compliant with the requirements of WHO GMP. To date, there are several APIs that have been approved by the SFDA and have been issued GMP certificates. The US FDA has completed an on-site pre- audit for several APIs. Some of APIs have registered DMF’s and some of OPEN PART of DMF have been prepared well.
To Weith Pharmaceutical, “Technology is productivity”, and the company allocates 30% of annual revenue to R&D and process optimization. Relying on key strengths in four plants, Weith Pharmaceutical converts newly developed technology into production.
There are over 20 kinds of APIs that are researched and developed by Weith Pharmaceutical, covering cancer, cardiovascular, and dermatology therapeutic segments. Weith Pharmaceutical has integrated well known domestic manufacturers of APIs and Intermediates into a rich product group that offers customer-oriented services. |
相關產品 |
|
Adapalene, Amorolfine HCL, Posaconazole, Voriconazole, Ailamode, Bortezomib, Fludarabine, Docetaxel, Risedronate Sodium, Zoledronic Acid, Entecavir, Alfuzosin HCL, Granisetron hcl, Adrenaline, Noradrenaline,Indobufen, Febuxostat, Ubenimex |
公司基本資料 |
|
公司名稱: |
Weith Pharamceutical(China) Technology Co.,Ltd. |
連絡: |
聯絡我們
|
網址: |
********
|
電話: |
86-21-62850293 |
傳真: |
86-21-68634546
|
國家: |
中國 |
住址: |
Floor12,Tower A,Yujing International Commercial Plaza,No.69,Dongfang Road,Pudong District |
|
產品櫥窗 |
|
|
|
|